Syrosingopine inhibits the degradation of sugars within the cells.
2.
The combination of metformin and syrosingopine also reduced or eliminated tumors in mice with malignant liver cancer.
3.
A combination of the diabetes drug metformin and syrosingopine killed tumor cells in blood samples from leukemia patients, while it did not damage blood cells in samples from healthy patients.